ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 024,75
-0,50%
Dow Jones
38 161,70
-0,58%
DAX
18 034,18
-0,54%
Brent Oil
85,805
-1,70%
Bitcoin
60 811,43
-4,74%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Natera Inc (NTRA)

  7. Natera Inc (NTRA) Actualités

NTRA Natera Inc

93,64
-0,40 (-0,43%)
Dernière mise à jour : 15:47:10
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Natera Inc NTRA NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
-0,40 -0,43% 93,64 15:47:10
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
93,06 92,10 93,76 94,04
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
22/4/202414:00BWNatera Announces Significant Milestone with 200+..
11/4/202414:00BWNatera Announces Publication of Largest Prospective dd-cfDNA..
08/4/202414:00BWNatera Announces New Data From Two Studies Extending the..
05/4/202413:00BWNatera Announces Positive Surveillance Analysis from the..
01/4/202414:00BWNatera and Alliance for Clinical Trials in Oncology Announce..
18/3/202412:00BWNatera Announces Phase III Randomized CIRCULATE Trial in..
14/3/202413:00BWNew KDIGO Guideline Supports Genetic Testing for the..
12/3/202413:00BWNatera to Present New Data at the 2024 SGO Annual Meeting on..
09/3/202402:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202403:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202403:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202403:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202403:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202403:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202403:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202403:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202414:00BWNatera Announces Commercial Coverage for Prospera™ Kidney..
05/3/202422:34EDGAR2Form 144 - Report of proposed sale of securities
02/3/202402:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/3/202402:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/3/202402:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/3/202402:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/3/202402:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/3/202402:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/3/202402:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202403:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202422:20EDGAR2Form 144 - Report of proposed sale of securities
29/2/202417:35EDGAR2Form 144 - Report of proposed sale of securities
29/2/202414:00BWNatera to Participate in March Investor Conferences
28/2/202422:11EDGAR2Form 8-K - Current report
28/2/202422:05BWNatera Reports Fourth Quarter and Full Year 2023 Financial..
27/2/202422:27EDGAR2Form 144 - Report of proposed sale of securities
27/2/202414:00BWNatera Announces Next Phase of CareDx Patent Infringement..
26/2/202413:00BWMedicare Extends Coverage of Natera’s Signatera™ MRD Test to..
24/2/202403:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/2/202414:00BWNatera Announces Fourth Quarter and Fiscal 2023 Earnings..
09/2/202403:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/2/202403:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202422:59EDGAR2Form 144 - Report of proposed sale of securities
06/2/202422:09EDGAR2Form 144 - Report of proposed sale of securities
05/2/202414:00BWNew Study Validates Signatera™ in Endometrial Cancer
03/2/202403:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/2/202422:47EDGAR2Form 144 - Report of proposed sale of securities
31/1/202403:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202403:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202403:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202403:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202403:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202403:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202403:01EDGAR2Form 3 - Initial statement of beneficial ownership of..

Dernières Valeurs Consultées

NASDAQ
NTRA
Natera
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés